Dimethyl Sulfoxide 5%/Gabapentin 5%/Ketoprofen 5%/Tetracaine 2% Transdermal Gel

The Dimethyl Sulfoxide 5%/Gabapentin 5%/Ketoprofen 5%/Tetracaine 2% Transdermal Gel is a compounded medication designed for topical application. This semisolid formulation is dispensed through a pump mechanism, which allows for easy and precise dosing. The gel base provides a suitable medium for the transdermal delivery of the active ingredients, ensuring that they are absorbed into the skin where they can exert their therapeutic effects locally.

Dimethyl Sulfoxide (DMSO) is known for its ability to penetrate the skin and enhance the absorption of other drugs, making it an ideal carrier for the active ingredients in this formulation. DMSO also has anti-inflammatory and analgesic properties, which contribute to the overall effectiveness of the gel.

In this transdermal formulation, Gabapentin may help to alleviate nerve-related pain by modulating the transmission of pain signals.

Ketoprofen is a nonsteroidal anti-inflammatory drug (NSAID) that provides analgesic and anti-inflammatory effects. It is commonly used for the treatment of musculoskeletal pain and inflammation, making it a valuable component of this compounded gel for patients suffering from conditions such as arthritis or soft tissue injuries.

Tetracaine is a local anesthetic that works by blocking sodium channels, which temporarily numbs the area to which it is applied. This can provide immediate relief from pain and discomfort on the skin's surface.

This unique combination of a carrier agent, a neuropathic pain reliever, an anti-inflammatory, and a local anesthetic makes the gel particularly suited for treating localized pain conditions, such as neuropathies, arthritis, and other musculoskeletal disorders. The transdermal route of administration ensures that the medication is delivered directly to the affected area, minimizing systemic absorption and potential side effects.

Patients and prescribers considering this formulation should be aware of the potential for skin irritation and should monitor for any adverse reactions. It is also important to consider the individual components' contraindications and interactions with other medications. As with any compounded medication, this formulation should be used under the guidance of a healthcare professional who can tailor the treatment to the specific needs of the patient.

If you have any questions or require further information about this transdermal gel formulation, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is dedicated to providing comprehensive support and guidance to ensure the safe and appropriate use of our compounded medications.

The transdermal gel formulation containing Dimethyl Sulfoxide (DMSO) 5%, Gabapentin 5%, Ketoprofen 5%, and Tetracaine 2% is designed for topical application and may offer localized relief from pain and inflammation. However, it is important to consider potential drug interactions when using this compound, especially if the patient is taking other medications or has underlying health conditions.

Dimethyl Sulfoxide (DMSO) can enhance the absorption of other compounds through the skin, which may increase the systemic exposure to the other active ingredients in the gel (Gabapentin, Ketoprofen, and Tetracaine) as well as any other topical medications applied to the same area. DMSO may also interact with certain oral medications, such as sedatives or anticoagulants, potentially altering their effects. Patients should be advised to inform their healthcare provider of all medications they are currently taking, including over-the-counter drugs and supplements.

Gabapentin, when used systemically, has been known to interact with antacids containing aluminum or magnesium, as they can reduce the bioavailability of gabapentin. Although the systemic absorption of gabapentin from the transdermal gel is expected to be lower than oral administration, patients should still be cautious when using antacids concurrently. Additionally, central nervous system depressants and alcohol may enhance the sedative effect of gabapentin, even if it is used topically.

Ketoprofen is a nonsteroidal anti-inflammatory drug (NSAID) that may interact with other NSAIDs, increasing the risk of gastrointestinal ulceration or bleeding. Caution is advised when using this gel in conjunction with other NSAIDs, including over-the-counter aspirin or ibuprofen. Ketoprofen can also interact with anticoagulants, antiplatelet agents, selective serotonin reuptake inhibitors (SSRIs), and serotonin-norepinephrine reuptake inhibitors (SNRIs), potentially increasing the risk of bleeding. Patients on such medications should consult their healthcare provider before using this transdermal gel.

Tetracaine is a local anesthetic and, although its systemic absorption is limited in a transdermal formulation, it may still contribute to additive systemic effects if used with other local anesthetics or medications that affect cardiac conduction. Patients with a history of heart disease or those taking antiarrhythmic drugs should use tetracaine-containing products with caution.

This transdermal gel is intended to treat localized pain, including neuropathic pain, inflammatory conditions, and certain types of acute pain. DMSO has anti-inflammatory and analgesic properties, Gabapentin is used for neuropathic pain, Ketoprofen is an NSAID that reduces inflammation and pain, and Tetracaine provides local anesthesia. The combination of these agents in a transdermal formulation allows for targeted application and potentially reduced systemic side effects.

It is crucial for patients and prescribers to be aware of these potential interactions and to monitor for adverse effects. If you have any questions or require further information regarding this formulation and its use, please reach out to us at Bayview Pharmacy. We are here to ensure the safe and appropriate use of compounded medications.

The Dimethyl Sulfoxide (DMSO) 5%/Gabapentin 5%/Ketoprofen 5%/Tetracaine 2% Transdermal Gel is a compounded medication designed to deliver active pharmaceutical ingredients through the skin directly to the site of pain or inflammation. This semisolid formulation is dispensed through a pump mechanism, which allows for easy and precise application. The gel-like consistency ensures that the medication stays where it is applied and facilitates the absorption of the active ingredients into the skin.

Dimethyl Sulfoxide (DMSO) is a solvent that has the ability to penetrate the skin and other biological membranes. In this formulation, DMSO serves as a carrier for the other active ingredients, enhancing their absorption through the skin. DMSO also has anti-inflammatory and analgesic properties, which contribute to the overall effectiveness of the formulation.

Gabapentin is a medication primarily used to treat neuropathic pain and seizures. In a topical formulation, gabapentin can target localized neuropathic pain by modulating the activity of certain neurotransmitters and reducing the pain signal transmission in the affected area.

Ketoprofen is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting the enzymes responsible for producing prostaglandins, which are compounds that cause pain, inflammation, and fever. By reducing the levels of prostaglandins, ketoprofen effectively alleviates inflammation and pain at the site of application.

Tetracaine is a local anesthetic that works by blocking the sodium channels in the nerve endings. This action prevents the initiation and transmission of nerve impulses, leading to a numbing effect in the area where the gel is applied. Tetracaine provides rapid and temporary relief from pain by desensitizing the affected area.

This combination of DMSO, gabapentin, ketoprofen, and tetracaine in a transdermal gel is particularly useful for treating localized pain conditions such as neuropathic pain, inflammatory conditions, and certain musculoskeletal disorders. The transdermal route of administration ensures that the medication has a localized effect, which minimizes systemic absorption and reduces the potential for systemic side effects.

Patients and prescribers considering this formulation should be aware of the individual components' actions and potential interactions. It is important to use this medication as directed by a healthcare professional and to report any adverse effects or concerns promptly. For any questions or additional information regarding this formulation, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide guidance and support to ensure the safe and appropriate use of this medication.

This particular compounding combination of Dimethyl Sulfoxide (DMSO) 5%, Gabapentin 5%, Ketoprofen 5%, and Tetracaine 2% in a transdermal gel is primarily formulated and dispensed for the purpose of managing pain, providing localized relief from various musculoskeletal conditions such as arthritis, neuropathic pain, and soft tissue inflammation. However, the versatility of the active ingredients allows for several other potential uses, which may be considered off-label. It's important to consult a healthcare provider for proper evaluation and authorization before using this gel for alternative indications.

DMSO is known for its ability to penetrate the skin and enhance the absorption of other medications, which could be beneficial in facilitating the deeper penetration of the other components in this formulation. Some anecdotal evidence suggests that DMSO may help with the management of complex regional pain syndrome (CRPS) due to its anti-inflammatory and analgesic properties. Gabapentin, commonly used for its anticonvulsant and neuropathic pain-relief effects, can potentially aid in conditions outside traditional neuropathies, like postherpetic neuralgia or fibromyalgia. However, evidence for these uses varies in rigor and confirmation.

Tetracaine, meanwhile, is a local anesthetic that can offer temporary relief from itching and pain caused by conditions such as minor burns or insect bites when compounded in this formulation.

It is worth noting that the safety profile, efficacy, and dosage for these alternative uses have not been as clearly established as they are for the primary indications. Therefore, any decision to use this transdermal gel for off-label purposes should be made in collaboration with a medical professional, considering the patient's unique medical history and specific health needs. Patient monitoring and follow-up are crucial to ensure appropriate use and to minimize potential side effects or drug interactions.

If you have any questions about this formulation or its potential other uses, please do not hesitate to reach out to us. Our team of compounding pharmacists at Bayview Pharmacy is committed to providing comprehensive information and support to ensure the safe and beneficial use of compounded medications.